Annual Working Capital
$476.98 M
+$160.58 M+50.75%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual working capital is $476.98 million, with the most recent change of +$160.58 million (+50.75%) on December 31, 2023.
- During the last 3 years, PLRX annual working capital has risen by +$197.82 million (+70.86%).
- PLRX annual working capital is now at all-time high.
Performance
PLRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$370.08 M
-$46.55 M-11.17%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly working capital is $370.08 million, with the most recent change of -$46.55 million (-11.17%) on September 30, 2024.
- Over the past year, PLRX quarterly working capital has dropped by -$46.55 million (-11.17%).
- PLRX quarterly working capital is now -34.51% below its all-time high of $565.07 million, reached on March 31, 2023.
Performance
PLRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PLRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.8% | -11.2% |
| 3 y3 years | +70.9% | -11.2% |
| 5 y5 years | +742.0% | +256.8% |
PLRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.6% | -34.5% | +145.1% |
| 5 y | 5-year | at high | +359.8% | -34.5% | +256.8% |
| alltime | all time | at high | +742.0% | -34.5% | +1459.5% |
Pliant Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $370.08 M(-11.2%) |
| Jun 2024 | - | $416.63 M(-9.3%) |
| Mar 2024 | - | $459.51 M(-3.7%) |
| Dec 2023 | $476.98 M(+50.8%) | $476.98 M(-5.9%) |
| Sep 2023 | - | $506.94 M(-5.5%) |
| Jun 2023 | - | $536.18 M(-5.1%) |
| Mar 2023 | - | $565.07 M(+78.6%) |
| Dec 2022 | $316.40 M(+64.3%) | $316.40 M(-6.9%) |
| Sep 2022 | - | $339.80 M(+125.1%) |
| Jun 2022 | - | $150.97 M(-9.6%) |
| Mar 2022 | - | $167.05 M(-13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $192.61 M(-31.0%) | $192.61 M(-10.7%) |
| Sep 2021 | - | $215.66 M(-10.1%) |
| Jun 2021 | - | $239.79 M(-7.9%) |
| Mar 2021 | - | $260.29 M(-6.8%) |
| Dec 2020 | $279.15 M(+169.1%) | $279.15 M(-5.9%) |
| Sep 2020 | - | $296.70 M(-5.0%) |
| Jun 2020 | - | $312.29 M(+87.5%) |
| Mar 2020 | - | $166.51 M(+60.5%) |
| Dec 2019 | $103.73 M(+83.1%) | $103.73 M(+330.2%) |
| Jun 2019 | - | $24.11 M(+1.6%) |
| Dec 2018 | $56.65 M | - |
| Dec 2018 | - | $23.73 M |
FAQ
- What is Pliant Therapeutics annual working capital?
- What is the all time high annual working capital for Pliant Therapeutics?
- What is Pliant Therapeutics annual working capital year-on-year change?
- What is Pliant Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly working capital year-on-year change?
What is Pliant Therapeutics annual working capital?
The current annual working capital of PLRX is $476.98 M
What is the all time high annual working capital for Pliant Therapeutics?
Pliant Therapeutics all-time high annual working capital is $476.98 M
What is Pliant Therapeutics annual working capital year-on-year change?
Over the past year, PLRX annual working capital has changed by +$160.58 M (+50.75%)
What is Pliant Therapeutics quarterly working capital?
The current quarterly working capital of PLRX is $370.08 M
What is the all time high quarterly working capital for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly working capital is $565.07 M
What is Pliant Therapeutics quarterly working capital year-on-year change?
Over the past year, PLRX quarterly working capital has changed by -$46.55 M (-11.17%)